Use of betulinic acid and its derivatives for inhibiting cancer growth and a method of monitoring this
US6048847A · kind A · utility
28Cited by
3References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 18, 1998 |
| Grant date | Apr 11, 2000 |
| Priority date | — |
| Expiry date | Mar 18, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07J53/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to use of betulinic acid and/or its derivatives for treating, inhibiting, and/or preventing tumors or cancer growth more particularly, to treating leukemia, lymphomas, lung, prostate and ovarian cancer. This invention also relates to novel betulinic acid derivatives and a composition containing betulinic acid derivatives with or without betulinic acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.